Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AAM Warns Of Dangerous Precedent In Vascepa 'Skinny Label' Case
Files Amicus Brief In Support Of Hikma Over Amarin Induced Infringement Claims
Sep 16 2021
•
By
David Wallace
The AAM has aired its views over carve-outs and induced infringement • Source: Alamy
More from Legal & IP
More from Generics Bulletin